Hugo Martinho

Hugo Martinho is a seasoned professional in the pharmaceutical industry with extensive experience in medical and regulatory affairs. From January 2018 to December 2023, Hugo served as the Medical & Regulatory Affairs Director and Medical Head for Biopharmaceuticals at AstraZeneca, focusing on improving health outcomes in cardiovascular, renal, metabolism, and respiratory diseases. Prior to AstraZeneca, Hugo held key roles at Abbott and Boehringer Ingelheim, including WESE Medical Lead for Dapagliflozin and Market Access Manager in Portugal, respectively. Hugo began a career in medical affairs at Novartis as a Medical Science Liaison for Diabetes. Academic credentials include a Master in Pharmaceutical Sciences from the University of Lisbon and a post-graduate degree in Medication Economic Assessment from Instituto Superior de Economia e Gestão.